BRL 2.66
(-16.88%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -76.09 Million | -92.22 Million | -64.06 Million | -9.6 Million | 34.82 Million | -33.57 Million |
Net Income | -60.5 Million | -94.41 Million | -80.87 Million | -62.55 Million | -18.4 Million | -12.93 Million |
Depreciation & Amortization | 29.14 Million | 23.17 Million | 15.5 Million | 13.74 Million | 12.7 Million | 7.59 Million |
Deferred income taxes | - | - | -2.02 Million | -2.54 Million | 4.02 Million | - |
Stock-based compensation | - | - | 1.82 Million | 222 Thousand | 138 Thousand | - |
Change in working capital | -44.93 Million | -27.59 Million | -13.64 Million | -5.75 Million | 28.01 Million | -33.73 Million |
Other non-cash items | 199 Thousand | 6.6 Million | 15.15 Million | 47.29 Million | 8.34 Million | 5.49 Million |
Investing Cash Flow | -37.27 Million | -69.77 Million | -25.6 Million | -8.49 Million | -10.48 Million | -23.13 Million |
Investments in PPE | -19.33 Million | -28.22 Million | -25.6 Million | -8.49 Million | -14.83 Million | -21.13 Million |
Acquisitions | -3.93 Million | -30.97 Million | - | - | 4.35 Million | -2 Million |
Investment purchases | -18.13 Million | -11.95 Million | - | - | - | - |
Sales/Maturities of investments | 4.12 Million | 1.38 Million | - | - | - | - |
Other Investing Activities | 1.00 | -10.19 Million | - | -8.25 Million | -14.77 Million | -20.53 Million |
Financing Cash Flow | -2.3 Million | 62.64 Million | 245.79 Million | -21.62 Million | 64.02 Million | 6.77 Million |
Debt repayment | -2.98 Million | -13.48 Million | -124.36 Million | -34.42 Million | -41.95 Million | -18.4 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | -6.44 Million | - | - | - | - |
Common Stock Issuance | - | 1.27 Million | 370.36 Million | - | - | - |
Other Financing Activities | -5.28 Million | 153.86 Million | -210 Thousand | 12.79 Million | 105.97 Million | 25.18 Million |
Accounts receivables | 2.42 Million | 4.49 Million | -12.6 Million | 22.1 Million | 10.86 Million | 5.05 Million |
Accounts payables | -24.4 Million | -1.25 Million | 15.09 Million | -11.76 Million | 6.46 Million | -8.48 Million |
Inventory | -1.2 Million | -175 Thousand | 580 Thousand | 108 Thousand | 2.38 Million | 3.1 Million |
Other working capital | -22.94 Million | -30.65 Million | -16.71 Million | -16.2 Million | 8.29 Million | -30.3 Million |
Cash at beginning of period | 166.54 Million | 265.89 Million | 109.78 Million | 149.51 Million | 61.14 Million | 111.07 Million |
Cash at end of period | 50.87 Million | 166.54 Million | 265.89 Million | 109.78 Million | 149.51 Million | 61.14 Million |
Capital Expenditure | -19.33 Million | -28.22 Million | -25.6 Million | -8.49 Million | -14.83 Million | -21.13 Million |
Effect of forex changes on cash | - | 4000.00 | - | - | - | - |
Net cash flow / Change in cash | -115.67 Million | -99.35 Million | 156.11 Million | -39.72 Million | 88.36 Million | -49.93 Million |
Free Cash Flow | -95.42 Million | -120.45 Million | -89.67 Million | -18.1 Million | 19.99 Million | -54.7 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -6.08 Million | -10.15 Million | -60.5 Million | -7.69 Million | -17.84 Million | -19.37 Million |
Depreciation & Amortization | 7.59 Million | 7.17 Million | 29.14 Million | 7.23 Million | 7.25 Million | 7.34 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -9.28 Million | -10.29 Million | -44.93 Million | -18.7 Million | 6.01 Million | -20.31 Million |
Other non-cash items | 22.08 Million | 15.2 Million | 199 Thousand | 5.77 Million | 14.99 Million | 1.25 Million |
Investing Cash Flow | 5 Million | -2.17 Million | -37.27 Million | -6.23 Million | -8.4 Million | -3.85 Million |
Investments in PPE | -2.99 Million | -3.33 Million | -19.33 Million | -4.12 Million | -4.34 Million | -5.17 Million |
Acquisitions | -646 Thousand | -2.47 Million | -3.93 Million | 3.93 Million | -3.14 Million | -796 Thousand |
Investment purchases | -34.26 Million | -493 Thousand | -18.13 Million | -2.64 Million | -3.11 Million | 7.02 Million |
Sales/Maturities of investments | 42.91 Million | 4.12 Million | 4.12 Million | 534 Thousand | 2.19 Million | -6.16 Million |
Other Investing Activities | -646 Thousand | -2.47 Million | 1.00 | -25.36 Million | -3.14 Million | 1.24 Million |
Financing Cash Flow | -11.58 Million | -10.1 Million | -2.3 Million | -703 Thousand | -13.94 Million | -4.79 Million |
Debt repayment | -11.52 Million | -5.51 Million | -2.98 Million | -2.73 Million | -8.27 Million | -14.17 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -66 Thousand | -4.59 Million | -5.28 Million | 2.02 Million | -5.66 Million | 9.37 Million |
Accounts receivables | -3.36 Million | 7.06 Million | 2.42 Million | -1.32 Million | 5.26 Million | -5.46 Million |
Accounts payables | -4.33 Million | -8.83 Million | -24.4 Million | -10.56 Million | -1.05 Million | -3 Million |
Inventory | - | 400 Thousand | -1.2 Million | -383 Thousand | -851 Thousand | 29 Thousand |
Other working capital | -1.58 Million | -8.51 Million | -22.94 Million | -6.81 Million | 2.66 Million | -11.88 Million |
Cash at beginning of period | 24.41 Million | 50.87 Million | 166.54 Million | 71.21 Million | 83.14 Million | -166.54 Million |
Cash at end of period | 9.26 Million | 24.41 Million | 50.87 Million | 50.87 Million | 71.21 Million | 83.14 Million |
Capital Expenditure | -2.99 Million | -3.33 Million | -19.33 Million | -4.12 Million | -4.34 Million | -5.17 Million |
Effect of forex changes on cash | - | - | - | - | - | 289.44 Million |
Net cash flow / Change in cash | -15.15 Million | -26.46 Million | -115.67 Million | -20.33 Million | -11.92 Million | 249.68 Million |
Free Cash Flow | -11.56 Million | -17.51 Million | -95.42 Million | -17.52 Million | 6.07 Million | -36.27 Million |
VLXC
MCLEODRUSS
MDRSF
KALYANCAP
BIOL
1072